Cargando…
Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment
BACKGROUND: The major obstacle impeding human immunodeficiency virus-1 (HIV-1) eradication in antiretroviral treatment (ART) treated HIV-1 subjects is the establishment of long-lived latently infected resting CD4(+) T cells. Due to the fact that no drug has been effective, the search for new drugs a...
Autores principales: | Relaño-Rodríguez, Ignacio, Juárez-Sánchez, Raquel, Pavicic, Carolina, Muñoz, Eduardo, Muñoz-Fernández, Maria Ángeles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529996/ https://www.ncbi.nlm.nih.gov/pubmed/31113488 http://dx.doi.org/10.1186/s12951-019-0500-4 |
Ejemplares similares
-
Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents
por: Relaño-Rodríguez, I., et al.
Publicado: (2021) -
Emergence of Nanotechnology to Fight HIV Sexual Transmission: The Trip of G2-S16 Polyanionic Carbosilane Dendrimer to Possible Pre-Clinical Trials
por: Relaño-Rodríguez, Ignacio, et al.
Publicado: (2020) -
Antiviral mechanism of polyanionic carbosilane dendrimers against HIV-1
por: Vacas-Córdoba, Enrique, et al.
Publicado: (2016) -
G2-S16 Polyanionic Carbosilane Dendrimer Can Reduce HIV-1 Reservoir Formation by Inhibiting Macrophage Cell to Cell Transmission
por: Relaño-Rodríguez, Ignacio, et al.
Publicado: (2021) -
Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen
por: Ceña-Diez, Rafael, et al.
Publicado: (2016)